rs1051905
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006408.4(AGR2):c.*224C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
AGR2
NM_006408.4 3_prime_UTR
NM_006408.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.24
Publications
1 publications found
Genes affected
AGR2 (HGNC:328): (anterior gradient 2, protein disulphide isomerase family member) This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, a catalytically active thioredoxin domain, and a C-terminal ER-retention sequence. This protein plays a role in cell migration, cellular transformation and metastasis and is as a p53 inhibitor. As an ER-localized molecular chaperone, it plays a role in the folding, trafficking, and assembly of cysteine-rich transmembrane receptors and the cysteine-rich intestinal gylcoprotein mucin. This gene has been implicated in inflammatory bowel disease and cancer progression. [provided by RefSeq, Mar 2017]
AGR2 Gene-Disease associations (from GenCC):
- respiratory infections, recurrent, and failure to thrive with or without diarrheaInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 310254Hom.: 0 Cov.: 3 AF XY: 0.00 AC XY: 0AN XY: 161940
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
310254
Hom.:
Cov.:
3
AF XY:
AC XY:
0
AN XY:
161940
African (AFR)
AF:
AC:
0
AN:
9126
American (AMR)
AF:
AC:
0
AN:
11176
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
10218
East Asian (EAS)
AF:
AC:
0
AN:
24448
South Asian (SAS)
AF:
AC:
0
AN:
19014
European-Finnish (FIN)
AF:
AC:
0
AN:
23404
Middle Eastern (MID)
AF:
AC:
0
AN:
1476
European-Non Finnish (NFE)
AF:
AC:
0
AN:
192448
Other (OTH)
AF:
AC:
0
AN:
18944
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.